Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.
Larrue C, Guiraud N, Mouchel PL, Dubois M, Farge T, Gotanègre M, Bosc C, Saland E, Nicolau-Travers ML, Sabatier M, Serhan N, Sahal A, Boet E, Mouche S, Heydt Q, Aroua N, Stuani L, Kaoma T, Angenendt L, Mikesch JH, Schliemann C, Vergez F, Tamburini J, Récher C, Sarry JE.
Larrue C, et al. Among authors: tamburini j.
Nat Commun. 2021 Jan 18;12(1):422. doi: 10.1038/s41467-020-20717-9.
Nat Commun. 2021.
PMID: 33462236
Free PMC article.